A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosis

A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosis

Abstract Background Calcific aortic stenosis (CAS) is the most common heart valve disease in the elderly, representing an important economic and social burden in developed countries. Currently, there is no way to predict either the onset or progression of CAS, emphasizing the need to identify useful...

Full description

Bibliographic Details
Main Authors: Tatiana Martin-Rojas, Laura Mourino-Alvarez, Felix Gil-Dones, Fernando de la Cuesta, Esther Rosello-Lleti, Carlos M. Laborde, Miguel Rivera, Luis Fernando Lopez-Almodovar, Juan Antonio Lopez, Finn Akerstrom, Luis R. Padial, Maria G. Barderas
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Clinical Proteomics
Subjects:
Calcific aortic stenosis
Multi-proteomic
Alpha 1 antichymotrypsin
Biomarker
Online Access:http://link.springer.com/article/10.1186/s12014-017-9147-z

Internet

http://link.springer.com/article/10.1186/s12014-017-9147-z

Similar Items